SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Acquired by Hillcrest Wealth Advisors NY LLC

Hillcrest Wealth Advisors NY LLC grew its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 101.8% during the 4th quarter, HoldingsChannel.com reports. The fund owned 14,363 shares of the exchange traded fund’s stock after buying an additional 7,245 shares during the quarter. SPDR S&P Biotech ETF makes up about 0.6% of Hillcrest Wealth Advisors NY LLC’s portfolio, making the stock its 25th largest holding. Hillcrest Wealth Advisors NY LLC’s holdings in SPDR S&P Biotech ETF were worth $1,294,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Hartline Investment Corp boosted its stake in SPDR S&P Biotech ETF by 2.0% during the 3rd quarter. Hartline Investment Corp now owns 5,502 shares of the exchange traded fund’s stock worth $544,000 after purchasing an additional 106 shares during the last quarter. Signature Estate & Investment Advisors LLC lifted its stake in shares of SPDR S&P Biotech ETF by 5.7% in the third quarter. Signature Estate & Investment Advisors LLC now owns 2,336 shares of the exchange traded fund’s stock worth $231,000 after buying an additional 125 shares in the last quarter. Denver Wealth Management Inc. boosted its position in SPDR S&P Biotech ETF by 0.9% during the third quarter. Denver Wealth Management Inc. now owns 14,779 shares of the exchange traded fund’s stock worth $1,460,000 after acquiring an additional 127 shares during the last quarter. Trust Co. of Vermont grew its stake in SPDR S&P Biotech ETF by 4.7% during the 3rd quarter. Trust Co. of Vermont now owns 3,058 shares of the exchange traded fund’s stock valued at $302,000 after acquiring an additional 138 shares in the last quarter. Finally, Graypoint LLC raised its holdings in SPDR S&P Biotech ETF by 5.6% in the 3rd quarter. Graypoint LLC now owns 2,738 shares of the exchange traded fund’s stock valued at $271,000 after acquiring an additional 146 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of SPDR S&P Biotech ETF stock opened at $92.46 on Friday. The stock’s 50 day simple moving average is $93.34 and its 200-day simple moving average is $96.88. The stock has a market cap of $7.05 billion, a P/E ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 1-year low of $81.14 and a 1-year high of $105.47.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.